新冠病毒细胞因子风暴：靶向合适的细胞因子。 - Suppr

COVID-19 cytokine storm: targeting the appropriate cytokine.

作者信息

Cron Randy Q

机构信息

Randy Cron, Children's of Alabama, Division of Rheumatology, University of Alabama at Birmingham, Birmingham, AL 35233-1711, USA.

出版信息

Lancet Rheumatol. 2021 Apr;3(4):e236-e237. doi: 10.1016/S2665-9913(21)00011-4. Epub 2021 Feb 3.

DOI:10.1016/S2665-9913(21)00011-4

PMID:33655221

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7906730/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da6a/7906730/cc939a21c39b/fx1.jpg

相似文献

COVID-19 cytokine storm: targeting the appropriate cytokine.

Lancet Rheumatol. 2021 Apr;3(4):e236-e237. doi: 10.1016/S2665-9913(21)00011-4. Epub 2021 Feb 3.

Coagulopathy as a Prodrome of Cytokine Storm in COVID-19-Infected Patients.

Front Med (Lausanne). 2020 Oct 23;7:572989. doi: 10.3389/fmed.2020.572989. eCollection 2020.

Nutraceutical Targeting of Inflammation-Modulating microRNAs in Severe Forms of COVID-19: A Novel Approach to Prevent the Cytokine Storm.

Front Pharmacol. 2020 Dec 11;11:602999. doi: 10.3389/fphar.2020.602999. eCollection 2020.

Therapeutic Prospects for Th-17 Cell Immune Storm Syndrome and Neurological Symptoms in COVID-19: Thiamine Efficacy and Safety, In-vitro Evidence and Pharmacokinetic Profile.

medRxiv. 2020 Aug 25:2020.08.23.20177501. doi: 10.1101/2020.08.23.20177501.

Targeting lymphocyte Kv1.3-channels to suppress cytokine storm in severe COVID-19: Can it be a novel therapeutic strategy?

Drug Discov Ther. 2020 Jul 15;14(3):143-144. doi: 10.5582/ddt.2020.03046. Epub 2020 Jun 25.

The Management of Cytokine Storm in COVID-19.

Acta Med Indones. 2020 Jul;52(3):306-313.

Cytokine Storm in Coronavirus Disease 2019 and Adult-Onset Still's Disease: Similarities and Differences.

Front Immunol. 2021 Jan 19;11:603389. doi: 10.3389/fimmu.2020.603389. eCollection 2020.

When Does the Cytokine Storm Begin in COVID-19 Patients? A Quick Score to Recognize It.

J Clin Med. 2021 Jan 15;10(2):297. doi: 10.3390/jcm10020297.

Silibinin and SARS-CoV-2: Dual Targeting of Host Cytokine Storm and Virus Replication Machinery for Clinical Management of COVID-19 Patients.

J Clin Med. 2020 Jun 7;9(6):1770. doi: 10.3390/jcm9061770.

Hemophagocytic lymphohistiocytosis: a review inspired by the COVID-19 pandemic.

Rheumatol Int. 2021 Jan;41(1):7-18. doi: 10.1007/s00296-020-04636-y. Epub 2020 Jun 25.

引用本文的文献

Hemophagocytic Lymphohistiocytosis Gene Variants in Severe COVID-19 Cytokine Storm Syndrome.

Viruses. 2025 Aug 8;17(8):1093. doi: 10.3390/v17081093.

Critical risks of haemoadsorption for COVID-19 patients and directions for future evaluations: a nationwide propensity score matched cohort study.

Sci Rep. 2025 Aug 9;15(1):29184. doi: 10.1038/s41598-025-13860-0.

A randomized, double-blind, placebo-controlled trial of IL-7 in critically ill patients with COVID-19.

JCI Insight. 2025 Feb 4;10(6):e189150. doi: 10.1172/jci.insight.189150.

IL-1 Family Blockade in Cytokine Storm Syndromes.

Adv Exp Med Biol. 2024;1448:553-563. doi: 10.1007/978-3-031-59815-9_36.

COVID-19 Pneumonia and Cytokine Storm Syndrome.

Adv Exp Med Biol. 2024;1448:307-319. doi: 10.1007/978-3-031-59815-9_22.

A Comparative Analysis of MicroRNA Expression in Mild, Moderate, and Severe COVID-19: Insights from Urine, Serum, and Nasopharyngeal Samples.

Biomolecules. 2023 Nov 21;13(12):1681. doi: 10.3390/biom13121681.

Prediction of Survival by IL-6 in a Randomized Placebo-Controlled Trial of Anakinra in COVID-19 Cytokine Storm.

Viruses. 2023 Sep 30;15(10):2036. doi: 10.3390/v15102036.

Cytokine-Induced iNOS in A549 Alveolar Epithelial Cells: A Potential Role in COVID-19 Lung Pathology.

Biomedicines. 2023 Oct 3;11(10):2699. doi: 10.3390/biomedicines11102699.

Leukopenia and leukocytosis as strong predictors of COVID-19 severity: A cross-sectional study of the hematologic abnormalities and COVID-19 severity in hospitalized patients.

Health Sci Rep. 2023 Sep 27;6(10):e1574. doi: 10.1002/hsr2.1574. eCollection 2023 Oct.

Role of Olive Bioactive Compounds in Respiratory Diseases.

Antioxidants (Basel). 2023 May 23;12(6):1140. doi: 10.3390/antiox12061140.

本文引用的文献

Interleukin-1 and interleukin-6 inhibition compared with standard management in patients with COVID-19 and hyperinflammation: a cohort study.

Lancet Rheumatol. 2021 Apr;3(4):e253-e261. doi: 10.1016/S2665-9913(21)00012-6. Epub 2021 Feb 3.

Efficacy of Tocilizumab in Patients Hospitalized with Covid-19.

N Engl J Med. 2020 Dec 10;383(24):2333-2344. doi: 10.1056/NEJMoa2028836. Epub 2020 Oct 21.

Clinical criteria for COVID-19-associated hyperinflammatory syndrome: a cohort study.

Lancet Rheumatol. 2020 Dec;2(12):e754-e763. doi: 10.1016/S2665-9913(20)30343-X. Epub 2020 Sep 29.

Preliminary predictive criteria for COVID-19 cytokine storm.

Ann Rheum Dis. 2021 Jan;80(1):88-95. doi: 10.1136/annrheumdis-2020-218323. Epub 2020 Sep 25.

Anakinra for severe forms of COVID-19: a cohort study.

Lancet Rheumatol. 2020 Jul;2(7):e393-e400. doi: 10.1016/S2665-9913(20)30164-8. Epub 2020 May 29.

Dexamethasone in Hospitalized Patients with Covid-19.

N Engl J Med. 2021 Feb 25;384(8):693-704. doi: 10.1056/NEJMoa2021436. Epub 2020 Jul 17.

On the Alert for Cytokine Storm: Immunopathology in COVID-19.

Arthritis Rheumatol. 2020 Jul;72(7):1059-1063. doi: 10.1002/art.41285. Epub 2020 May 10.

Macrophage Activation Syndrome and Secondary Hemophagocytic Lymphohistiocytosis in Childhood Inflammatory Disorders: Diagnosis and Management.

Paediatr Drugs. 2020 Feb;22(1):29-44. doi: 10.1007/s40272-019-00367-1.

Benefit of Anakinra in Treating Pediatric Secondary Hemophagocytic Lymphohistiocytosis.

Arthritis Rheumatol. 2020 Feb;72(2):326-334. doi: 10.1002/art.41103. Epub 2019 Dec 26.

The Immunology of Macrophage Activation Syndrome.

Front Immunol. 2019 Feb 1;10:119. doi: 10.3389/fimmu.2019.00119. eCollection 2019.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

COVID-19 cytokine storm: targeting the appropriate cytokine.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

本文引用的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献

本文引用的文献